AGN 1.33% 74.0¢ argenica therapeutics limited

Lol reon1 if you say that the design covers all conditions and...

  1. 293 Posts.
    lightbulb Created with Sketch. 28
    Lol reon1 if you say that the design covers all conditions and think the dose will be the same all for not having another phase 1 trial. Let’s focus on the current phase 2 trial, safety data expected in October and that will help the share price for sure
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.